Expert Q&A: Labs Must Take a Greater Role in Guiding Clinicians About Abnormal Data
Lee Fleisher, MD, advocates for clearer interpretation of test results by medical laboratory scientists
Keep up to date on the latest legal, compliance, and business developments affecting the lab industry, while offering analysis and insight to ensure your lab’s success.
Lee Fleisher, MD, advocates for clearer interpretation of test results by medical laboratory scientists
Part of the duty to protect workers is to ensure those at risk receive proper training on what to do if an active shooter incident occurs.
Legal team’s bid to dismiss part of CMS inspector’s testimony as hearsay is denied by the Northern District of California federal court.
Caris Life Sciences agrees to pay $2.8 million to settle claims that it purposely delayed submitting lab tests to get around Medicare’s 14-day rule.
Here are the two key CLFS changes, set to take effect on July 1, 2022, that your billing staff needs to know about.
If your lab received federal relief funds from the US government during the COVID-19 pandemic, you could be at risk of FCA lawsuits.
The most recent congressional effort to pass LDT legislation may prove to be the one that finally comes to fruition.
Two of the biggest merger and acquisition-related deals that came down in May involved BioMérieux and Sema4
Senate committee members propose a modified version of legislation allowing the FDA to continue to regulate LDTs on a risk-tiered basis.
Companies will explore LabDroid’s capacity to automate sample preparation workflows for long-read sequencing systems.
Companies are using the lessons learned from COVID-19 to get out of the box quickly in developing test kits for monkeypox.